Kivo reports that access to clinical trials varies significantly by state, with Massachusetts leading and Mississippi lagging behind in availability.

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

Pharmacists reviewing a new drug in a laboratory. There are more medical treatments available today than ever before, and yet each day, someone new is diagnosed with a condition for which effective ...